ICA inhibited the expression of Axl receptor tyrosine kinase and immune checkpoint molecules in melanoma cells in vitro and improved the therapeutic response to cisplatin in mouse melanoma xenografts in vivo [46]. The gene discussed is AXL; the disease is melanoma.